A Placebo-Controlled Double Blind Comparative Study of JNS007ER in Patients With Schizophrenia.

Trial Profile

A Placebo-Controlled Double Blind Comparative Study of JNS007ER in Patients With Schizophrenia.

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Jan 2013

At a glance

  • Drugs Paliperidone (Primary) ; Olanzapine
  • Indications Schizophrenia
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 27 Mar 2012 Actual patient number (228) added as reported by ClinicalTrials.gov (Extension trial: NCT01561898).
    • 27 Mar 2012 Actual patient number (228) added as reported by ClinicalTrials.gov (Extension trial: NCT01561898).
    • 27 Mar 2012 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov (Extension trial: NCT01561898).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top